1969New England Journal of MedicineRequires access

Propranolol Combined with Isosorbide Dinitrate versus Placebo in Angina Pectoris

Wilbert S. Aronow, Marvin A. Kaplan

Open publisher page 45 citations

Abstract

Sublingual isosorbide dinitrate, 5 mg, combined with oral propranolol, 40 mg, was given four times daily for six weeks to 23 patients with angina pectoris. The effects were compared with those of appropriate placebos. Three patients (13 per cent) were unable to tolerate the drugs, seven (30 per cent) had fewer anginal attacks on the drugs, 10 (44 per cent) had fewer anginal episodes on the placebos, and three (13 per cent) had a similar number of anginal attacks on both drugs and on placebos. Five of 20 patients (25 per cent) had improved exercise performance on the drugs, and 15 (75 per cent) on the placebos. There was a significantly improved exercise performance in two patients (10 per cent) on the drugs and in eight (40 per cent) on the placebos. Propranolol and isosorbide dinitrate may harm as well as benefit patients with angina pectoris.

About this research paper

What this paper is about

Sublingual isosorbide dinitrate, 5 mg, combined with oral propranolol, 40 mg, was given four times daily for six weeks to 23 patients with angina pectoris. The effects were compared with those of appropriate placebos. Three patients (13 per cent) were unable to tolerate the drugs, seven (30 per cent) had fewer anginal attacks on the drugs, 10 (44 per cent) had fewer anginal episodes on the placebos, and three (13 per cent) had a similar number of anginal attacks on both drugs and on placebos. Five of 20 patients (25 per cent) had improved exercise performance on the drugs, and 15 (75 per cent) on the placebos. There was a significantly improved exercise performance in two patients (10 per cent) on the drugs and in eight (40 per cent) on the placebos. Propranolol and isosorbide dinitrate may harm as well as benefit patients with angina pectoris.

Why it matters

OpenAlex reports 45 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Sublingual isosorbide dinitrate, 5 mg, combined with oral propranolol, 40 mg, was given four times daily for six weeks to 23 patients with angina pectoris. The effects were compared with those of appropriate placebos. Three patients (13 per cent) were unable to tolerate the drugs, seven (30 per cent) had fewer anginal attacks on the drugs, 10 (44 per cent) had fewer anginal episodes on the placebos, and three (13 per cent) had a similar number of anginal attacks on both drugs and on placebos. Five of 20 patients (25 per cent) had improved exercise performance on the drugs, and 15 (75 per cent) on the placebos. There was a significantly improved exercise performance in two patients (10 per cent) on the drugs and in eight (40 per cent) on the placebos. Propranolol and isosorbide dinitrate may harm as well as benefit patients with angina pectoris.

Key concepts: Isosorbide dinitrate, Medicine, Angina, Propranolol, Placebo, Isosorbide, Anesthesia, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Propranolol Combined with Isosorbide Dinitrate versus Placebo in Angina Pectoris — Research Paper | ScholarLens